Canadian cohort expanded-access program of nivolumab plus ipilimumab in advanced melanoma

BACKGROUND: The combination of nivolumab and ipilimumab is approved in several jurisdictions (United States, European Union, Canada) for the first-line treatment of patients with advanced melanoma. CheckMate 218 is a North American expanded-access program (eap) of nivolumab plus ipilimumab in patien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Curr Oncol
Autores principales: Hogg, D., Monzon, J.G., Ernst, S., Song, X., McWhirter, E., Savage, K.J., Skinn, B., Romeyer, F., Smylie, M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Multimed Inc. 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467793/
https://ncbi.nlm.nih.gov/pubmed/32905202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5985
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares